Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-12-21 to 2023-12-22
Current total value of award: $6252.21
Description: 4563159994!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML